Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Pharmacy Benefit Managers (PBMs)
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Display Only
Showing 1216 Results
From Theory to Practice: Addressing the Gaps of the ACO Medication Readiness Assessment
When the American Medical Group Association, Premier Inc., the Dartmouth Institute and NPC fielded a readiness assessment examining accountable care organizations’ (ACO) capabilities to support,…
Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management
This case study explores the important role that pharmacists can play in ensuring the optimal use of pharmaceuticals and improving patient outcomes in an accountable care organization (ACO). It …
#TBT: Thanksgiving, Gratitude & Health Benefits
Normally we’d be featuring previous research, videos or commentaries as part of our “Throwback Thursday” blog series today, but we decided to take the day off and reflect on the spirit of…
Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?
Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?,” addressing the “issues surrounding…
#TBT: Why Patient Differences Matter, Especially When It Comes to Cancer Treatments
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
#TBT: Health Care Quality Has Long Been an Important Issue
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
Accountable Care Measures for High-Cost Specialty Care and Innovative Treatment
This comprehensive white paper from the National Pharmaceutical Council and Discern Health identified gaps in accountable care quality measure sets for cancer, which can lead to missed opportunities…
#TBT: National Boss’ Day—Celebrating Dan Leonard’s Six Years of Leadership
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
A Day in the Life: Dr. Shih Talks About His NPC-Milken Institute SPH Fellowship
In 2012, the National Pharmaceutical Council (NPC) and the Milken Institute School of Public Health (Milken Institute SPH) at The George Washington University partnered to create a two-year post…
Assessing the Value of Drugs for Formulary Decisions
Some of the National Pharmaceutical Council's (NPC) research partners participated today on a panel, "Best Practices for Assessing the Value of Drugs for Formulary Decisions," at the Academy of…
#TBT: Ask Your Pharmacist—It’s American Pharmacists Month
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
How Much Pay for How Much Performance?
A new commentary from National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, looks at some potential repercussions of the shift from a fee-for-service provider compensation…
Consumer-Directed Health Plans: Pharmacy Benefits & "Better Practices"
The research was intended to identify the current landscape and best practice approaches for consumer-directed health plans and pharmacy benefits, as well as understand the health and economic impact…
#TBT: National Cheeseburger Day & National Cholesterol Education Month
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…